Harmony Biosciences Holdings (HRMY) Net Income (2019 - 2026)
Harmony Biosciences Holdings' Net Income came in at $75.43 million for Q2 2026, up 89.6% from $39.78 million a year earlier and up 132.2% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Net Income (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Harmony Biosciences Holdings reported Net Income of $181.27 million, up 0.2% year-over-year; for FY2025, it came in at $158.69 million, up 9.1% from FY2024.
- Going back by year, Net Income was $145.49 million in FY2024 (+12.9%), $128.85 million in FY2023 (-29.0%), $181.47 million in FY2022 (+424.5%) and $34.6 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Net Income since Q3 2022.
- Year-over-year, Net Income increased in six of the last eight quarters, with growth averaging 48.1%.
- The fastest year-over-year change in Net Income over five years came in Q2 2025 (growth of 243.2%), and the weakest in Q2 2024 (a decline of 66.2%).
- Business Quant data shows HRMY's Net Income at $32.49 million (Q1 2026), $22.49 million (Q4 2025) and $50.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 75.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.43 Mn |
| Mar 31, 2026 | 32.49 Mn |
| Dec 31, 2025 | 22.49 Mn |
| Sep 30, 2025 | 50.87 Mn |
| Jun 30, 2025 | 39.78 Mn |
| Mar 31, 2025 | 45.56 Mn |
| Dec 31, 2024 | 49.48 Mn |
| Sep 30, 2024 | 46.09 Mn |
| Jun 30, 2024 | 11.59 Mn |
| Mar 31, 2024 | 38.33 Mn |
| Dec 31, 2023 | 26.61 Mn |
| Sep 30, 2023 | 38.46 Mn |
| Jun 30, 2023 | 34.30 Mn |
| Mar 31, 2023 | 29.49 Mn |
| Dec 31, 2022 | 48.51 Mn |
| Sep 30, 2022 | 87.94 Mn |
| Jun 30, 2022 | 23.53 Mn |
| Mar 31, 2022 | 21.49 Mn |
| Dec 31, 2021 | 22.71 Mn |
| Sep 30, 2021 | -9.62 Mn |
API Access
Harmony Biosciences Holdings Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();